Skip to main content

Rallybio Corp

RLYB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001739410

No open-market purchases or sales by Rallybio Corp insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $65.0M in total; Viking Global Investors is the only superinvestor holding it.

Q2 2023 vs. Q1 2023

How the institutions holding Rallybio Corp changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of RLYB: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders5359+6
Shares32.1M33.3M+1.15M (+3.6%)
Value$183.3M$188.3M+$4.92M (+2.7%)

New holders (11)

Institutions that held Rallybio Corp at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to RLYB in Q2 2023
InstitutionSharesValue% of portfolio
Bridgeway Capital Management, LLC18,000$101.9K0.00%
MetLife Investment Management16,979$96.1K0.00%
Manufacturers Life Insurance Company, The13,144$74.4K0.00%
Price T Rowe Associates Inc12,770$74.0K0.00%
Voya Investment Management LLC12,492$70.7K0.00%
Millennium Management LLC10,141$57.4K0.00%
Citigroup Inc9,129$51.7K0.00%
Metropolitan Life Insurance Co1,759$9.96K0.00%
Allspring Global Investments Holdings, LLC465$2.63K0.00%
Russell Investments Group, Ltd.273$1.54K0.00%
Toronto Dominion Bank107$1.00K0.00%

Sold out (5)

Institutions that held Rallybio Corp at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of RLYB in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Vontobel Holding Ltd.175,977$1.00M
DekaBank Deutsche Girozentrale30,000$168.0K
State of Tennessee, Treasury Department16,625$94.9K
Ergoteles LLC10,068$57.5K
Nisa Investment Advisors, LLC18$0